Skip to main content

Table 2 Univariate analysis of PFS in 73 patients with LS-SCLC treated with early CCRT

From: Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Variable Univariate analysis
Relative risk 95% CI P value
Sex, male 1.37 0.69–3.02 0.3983
Age, ≥ 70 years 0.80 0.39–1.53 0.5190
ECOG-PS = 0 0.81 0.45–1.48 0.4867
Clinical stage III 1.22 0.61–2.69 0.5967
Pre-existing ILAs 1.55 0.67–3.16 0.2579
  1. PFS, progression-free survival; LS-SCLC, limited-stage small-cell lung cancer; CCRT, concurrent chemoradiotherapy; CI, confidence interval; ECOG-PS, Eastern Cooperative Oncology Group performance status; ILA, interstitial lung abnormality